Left atrial size predicts long-term outcome after balloon mitral valvuloplasty
BACKGROUND: The treatment of choice for severe rheumatic mitral stenosis is balloon mitral valvuloplasty(BMV). Numerous predictors of immediate and long-term procedural success have beendescribed. The aims of this study were to describe our experience with BMV over the last decade and toevaluate pre...
Gespeichert in:
Veröffentlicht in: | Cardiology journal 2023-10, Vol.30 (5), p.753-761 |
---|---|
Hauptverfasser: | , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 761 |
---|---|
container_issue | 5 |
container_start_page | 753 |
container_title | Cardiology journal |
container_volume | 30 |
creator | Canetti, Michal Kuperstein, Rafael Cohen, Ido Raibman-Spector, Shir Maor, Elad Hai, Ilan Barbash, Israel M. Regev, Ehud Butnaru, Adi Segev, Amit Guetta, Victor Fefer, Paul |
description | BACKGROUND: The treatment of choice for severe rheumatic mitral stenosis is balloon mitral valvuloplasty(BMV). Numerous predictors of immediate and long-term procedural success have beendescribed. The aims of this study were to describe our experience with BMV over the last decade and toevaluate predictors of long-term event-free survival. METHODS: Medical records were retrospectively analyzed of patients who underwent BMV between2009 and 2021. The primary outcome was a composite endpoint of all-cause mortality, mitral valvereplacement (MVR), and repeat BMV. Long-term event-free survival was estimated using Kaplan-Meiercurves. Logistic regression was used to create a multivariate model to assess pre-procedural predictorsof the primary outcome. RESULTS: A total of 96 patients underwent BMV during the study period. The primary outcome occurredin 36 patients during 12-year follow-up: one (1%) patient underwent re-BMV, 28 (29%) underwentMVR, and eight (8%) died. Overall, event-free survival was 62% at 12 years. On multivariate analysis,pre-procedural left atrial volume index (LAVI) > 80 mL/m2 had a significant independent influenceon event-free survival, as did previous mitral valve procedure and systolic pulmonary arterial pressureabove 50 mmHg. CONCLUSIONS: Despite being a relatively low-volume center, excellent short and long-term results weredemonstrated, with event-free survival rates consistent with previous studies from high-volume centers.LAVI independently predicted long-term event-free survival. |
doi_str_mv | 10.5603/CJ.a2022.0092 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10635716</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2722314134</sourcerecordid><originalsourceid>FETCH-LOGICAL-c349t-7ae531705142dfea14d14b383405883a76a74a5577e859cb0ab95f92b32465603</originalsourceid><addsrcrecordid>eNpdkUtLLDEQhYMovpfuG9y46bHy6iQruQzXF4NuFNyF6p60tqQ7c5P0gPfX26Mi6KqqqK8O51CEnFCYyQr4-fx2hgwYmwEYtkX2qTa6BKqftj96VUpp-B45SOkVoDJSsl2yxysGIIXaJ3cL1-YCc-zQF6n774pVdMuuyanwYXgus4t9EcbchN4V2E5jUaP3IQxF3-U4Ha3Rr0cfVh5TfjsiOy365I6_6iF5vPz7ML8uF_dXN_M_i7LhwuRSoZOcKpBUsGXrkIolFTXXXIDUmqOqUAmUUimnpWlqwNrI1rCaM1FtYh-Si0_d1Vj3btm4YePFrmLXY3yzATv7czN0L_Y5rC2FiktFq0nh7Eshhn-jS9n2XWqc9zi4MCbLFGOcCsrFhJ7-Ql_DGIcpn2VaV8IYADVR5SfVxJBSdO23Gwp249nOb-3Hq-zmVfwd5aWFAw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2886499007</pqid></control><display><type>article</type><title>Left atrial size predicts long-term outcome after balloon mitral valvuloplasty</title><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Canetti, Michal ; Kuperstein, Rafael ; Cohen, Ido ; Raibman-Spector, Shir ; Maor, Elad ; Hai, Ilan ; Barbash, Israel M. ; Regev, Ehud ; Butnaru, Adi ; Segev, Amit ; Guetta, Victor ; Fefer, Paul</creator><creatorcontrib>Canetti, Michal ; Kuperstein, Rafael ; Cohen, Ido ; Raibman-Spector, Shir ; Maor, Elad ; Hai, Ilan ; Barbash, Israel M. ; Regev, Ehud ; Butnaru, Adi ; Segev, Amit ; Guetta, Victor ; Fefer, Paul</creatorcontrib><description>BACKGROUND: The treatment of choice for severe rheumatic mitral stenosis is balloon mitral valvuloplasty(BMV). Numerous predictors of immediate and long-term procedural success have beendescribed. The aims of this study were to describe our experience with BMV over the last decade and toevaluate predictors of long-term event-free survival. METHODS: Medical records were retrospectively analyzed of patients who underwent BMV between2009 and 2021. The primary outcome was a composite endpoint of all-cause mortality, mitral valvereplacement (MVR), and repeat BMV. Long-term event-free survival was estimated using Kaplan-Meiercurves. Logistic regression was used to create a multivariate model to assess pre-procedural predictorsof the primary outcome. RESULTS: A total of 96 patients underwent BMV during the study period. The primary outcome occurredin 36 patients during 12-year follow-up: one (1%) patient underwent re-BMV, 28 (29%) underwentMVR, and eight (8%) died. Overall, event-free survival was 62% at 12 years. On multivariate analysis,pre-procedural left atrial volume index (LAVI) > 80 mL/m2 had a significant independent influenceon event-free survival, as did previous mitral valve procedure and systolic pulmonary arterial pressureabove 50 mmHg. CONCLUSIONS: Despite being a relatively low-volume center, excellent short and long-term results weredemonstrated, with event-free survival rates consistent with previous studies from high-volume centers.LAVI independently predicted long-term event-free survival.</description><identifier>ISSN: 1897-5593</identifier><identifier>EISSN: 1898-018X</identifier><identifier>DOI: 10.5603/CJ.a2022.0092</identifier><identifier>PMID: 36200547</identifier><language>eng</language><publisher>Gdansk: Wydawnictwo Via Medica</publisher><subject>Calcification ; Cardiac arrhythmia ; Cardiology ; Clinical Cardiology ; Flow velocity ; Heart ; Hemodynamics ; Mortality ; Patients ; Pulmonary arteries ; Regression analysis ; Success</subject><ispartof>Cardiology journal, 2023-10, Vol.30 (5), p.753-761</ispartof><rights>2023. This work is published under https://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>Copyright © 2023 Via Medica 2023</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10635716/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10635716/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,860,881,27901,27902,53766,53768</link.rule.ids></links><search><creatorcontrib>Canetti, Michal</creatorcontrib><creatorcontrib>Kuperstein, Rafael</creatorcontrib><creatorcontrib>Cohen, Ido</creatorcontrib><creatorcontrib>Raibman-Spector, Shir</creatorcontrib><creatorcontrib>Maor, Elad</creatorcontrib><creatorcontrib>Hai, Ilan</creatorcontrib><creatorcontrib>Barbash, Israel M.</creatorcontrib><creatorcontrib>Regev, Ehud</creatorcontrib><creatorcontrib>Butnaru, Adi</creatorcontrib><creatorcontrib>Segev, Amit</creatorcontrib><creatorcontrib>Guetta, Victor</creatorcontrib><creatorcontrib>Fefer, Paul</creatorcontrib><title>Left atrial size predicts long-term outcome after balloon mitral valvuloplasty</title><title>Cardiology journal</title><description>BACKGROUND: The treatment of choice for severe rheumatic mitral stenosis is balloon mitral valvuloplasty(BMV). Numerous predictors of immediate and long-term procedural success have beendescribed. The aims of this study were to describe our experience with BMV over the last decade and toevaluate predictors of long-term event-free survival. METHODS: Medical records were retrospectively analyzed of patients who underwent BMV between2009 and 2021. The primary outcome was a composite endpoint of all-cause mortality, mitral valvereplacement (MVR), and repeat BMV. Long-term event-free survival was estimated using Kaplan-Meiercurves. Logistic regression was used to create a multivariate model to assess pre-procedural predictorsof the primary outcome. RESULTS: A total of 96 patients underwent BMV during the study period. The primary outcome occurredin 36 patients during 12-year follow-up: one (1%) patient underwent re-BMV, 28 (29%) underwentMVR, and eight (8%) died. Overall, event-free survival was 62% at 12 years. On multivariate analysis,pre-procedural left atrial volume index (LAVI) > 80 mL/m2 had a significant independent influenceon event-free survival, as did previous mitral valve procedure and systolic pulmonary arterial pressureabove 50 mmHg. CONCLUSIONS: Despite being a relatively low-volume center, excellent short and long-term results weredemonstrated, with event-free survival rates consistent with previous studies from high-volume centers.LAVI independently predicted long-term event-free survival.</description><subject>Calcification</subject><subject>Cardiac arrhythmia</subject><subject>Cardiology</subject><subject>Clinical Cardiology</subject><subject>Flow velocity</subject><subject>Heart</subject><subject>Hemodynamics</subject><subject>Mortality</subject><subject>Patients</subject><subject>Pulmonary arteries</subject><subject>Regression analysis</subject><subject>Success</subject><issn>1897-5593</issn><issn>1898-018X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>BENPR</sourceid><recordid>eNpdkUtLLDEQhYMovpfuG9y46bHy6iQruQzXF4NuFNyF6p60tqQ7c5P0gPfX26Mi6KqqqK8O51CEnFCYyQr4-fx2hgwYmwEYtkX2qTa6BKqftj96VUpp-B45SOkVoDJSsl2yxysGIIXaJ3cL1-YCc-zQF6n774pVdMuuyanwYXgus4t9EcbchN4V2E5jUaP3IQxF3-U4Ha3Rr0cfVh5TfjsiOy365I6_6iF5vPz7ML8uF_dXN_M_i7LhwuRSoZOcKpBUsGXrkIolFTXXXIDUmqOqUAmUUimnpWlqwNrI1rCaM1FtYh-Si0_d1Vj3btm4YePFrmLXY3yzATv7czN0L_Y5rC2FiktFq0nh7Eshhn-jS9n2XWqc9zi4MCbLFGOcCsrFhJ7-Ql_DGIcpn2VaV8IYADVR5SfVxJBSdO23Gwp249nOb-3Hq-zmVfwd5aWFAw</recordid><startdate>20231027</startdate><enddate>20231027</enddate><creator>Canetti, Michal</creator><creator>Kuperstein, Rafael</creator><creator>Cohen, Ido</creator><creator>Raibman-Spector, Shir</creator><creator>Maor, Elad</creator><creator>Hai, Ilan</creator><creator>Barbash, Israel M.</creator><creator>Regev, Ehud</creator><creator>Butnaru, Adi</creator><creator>Segev, Amit</creator><creator>Guetta, Victor</creator><creator>Fefer, Paul</creator><general>Wydawnictwo Via Medica</general><general>Via Medica</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PHGZM</scope><scope>PHGZT</scope><scope>PIMPY</scope><scope>PKEHL</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20231027</creationdate><title>Left atrial size predicts long-term outcome after balloon mitral valvuloplasty</title><author>Canetti, Michal ; Kuperstein, Rafael ; Cohen, Ido ; Raibman-Spector, Shir ; Maor, Elad ; Hai, Ilan ; Barbash, Israel M. ; Regev, Ehud ; Butnaru, Adi ; Segev, Amit ; Guetta, Victor ; Fefer, Paul</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c349t-7ae531705142dfea14d14b383405883a76a74a5577e859cb0ab95f92b32465603</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Calcification</topic><topic>Cardiac arrhythmia</topic><topic>Cardiology</topic><topic>Clinical Cardiology</topic><topic>Flow velocity</topic><topic>Heart</topic><topic>Hemodynamics</topic><topic>Mortality</topic><topic>Patients</topic><topic>Pulmonary arteries</topic><topic>Regression analysis</topic><topic>Success</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Canetti, Michal</creatorcontrib><creatorcontrib>Kuperstein, Rafael</creatorcontrib><creatorcontrib>Cohen, Ido</creatorcontrib><creatorcontrib>Raibman-Spector, Shir</creatorcontrib><creatorcontrib>Maor, Elad</creatorcontrib><creatorcontrib>Hai, Ilan</creatorcontrib><creatorcontrib>Barbash, Israel M.</creatorcontrib><creatorcontrib>Regev, Ehud</creatorcontrib><creatorcontrib>Butnaru, Adi</creatorcontrib><creatorcontrib>Segev, Amit</creatorcontrib><creatorcontrib>Guetta, Victor</creatorcontrib><creatorcontrib>Fefer, Paul</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>ProQuest Central (New)</collection><collection>ProQuest One Academic (New)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Middle East (New)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Cardiology journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Canetti, Michal</au><au>Kuperstein, Rafael</au><au>Cohen, Ido</au><au>Raibman-Spector, Shir</au><au>Maor, Elad</au><au>Hai, Ilan</au><au>Barbash, Israel M.</au><au>Regev, Ehud</au><au>Butnaru, Adi</au><au>Segev, Amit</au><au>Guetta, Victor</au><au>Fefer, Paul</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Left atrial size predicts long-term outcome after balloon mitral valvuloplasty</atitle><jtitle>Cardiology journal</jtitle><date>2023-10-27</date><risdate>2023</risdate><volume>30</volume><issue>5</issue><spage>753</spage><epage>761</epage><pages>753-761</pages><issn>1897-5593</issn><eissn>1898-018X</eissn><abstract>BACKGROUND: The treatment of choice for severe rheumatic mitral stenosis is balloon mitral valvuloplasty(BMV). Numerous predictors of immediate and long-term procedural success have beendescribed. The aims of this study were to describe our experience with BMV over the last decade and toevaluate predictors of long-term event-free survival. METHODS: Medical records were retrospectively analyzed of patients who underwent BMV between2009 and 2021. The primary outcome was a composite endpoint of all-cause mortality, mitral valvereplacement (MVR), and repeat BMV. Long-term event-free survival was estimated using Kaplan-Meiercurves. Logistic regression was used to create a multivariate model to assess pre-procedural predictorsof the primary outcome. RESULTS: A total of 96 patients underwent BMV during the study period. The primary outcome occurredin 36 patients during 12-year follow-up: one (1%) patient underwent re-BMV, 28 (29%) underwentMVR, and eight (8%) died. Overall, event-free survival was 62% at 12 years. On multivariate analysis,pre-procedural left atrial volume index (LAVI) > 80 mL/m2 had a significant independent influenceon event-free survival, as did previous mitral valve procedure and systolic pulmonary arterial pressureabove 50 mmHg. CONCLUSIONS: Despite being a relatively low-volume center, excellent short and long-term results weredemonstrated, with event-free survival rates consistent with previous studies from high-volume centers.LAVI independently predicted long-term event-free survival.</abstract><cop>Gdansk</cop><pub>Wydawnictwo Via Medica</pub><pmid>36200547</pmid><doi>10.5603/CJ.a2022.0092</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1897-5593 |
ispartof | Cardiology journal, 2023-10, Vol.30 (5), p.753-761 |
issn | 1897-5593 1898-018X |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10635716 |
source | DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; Alma/SFX Local Collection |
subjects | Calcification Cardiac arrhythmia Cardiology Clinical Cardiology Flow velocity Heart Hemodynamics Mortality Patients Pulmonary arteries Regression analysis Success |
title | Left atrial size predicts long-term outcome after balloon mitral valvuloplasty |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-21T21%3A41%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Left%20atrial%20size%20predicts%20long-term%20outcome%20after%20balloon%20mitral%20valvuloplasty&rft.jtitle=Cardiology%20journal&rft.au=Canetti,%20Michal&rft.date=2023-10-27&rft.volume=30&rft.issue=5&rft.spage=753&rft.epage=761&rft.pages=753-761&rft.issn=1897-5593&rft.eissn=1898-018X&rft_id=info:doi/10.5603/CJ.a2022.0092&rft_dat=%3Cproquest_pubme%3E2722314134%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2886499007&rft_id=info:pmid/36200547&rfr_iscdi=true |